Suppr超能文献

致癌性表皮生长因子/ Ras 信号和 Ets 转录因子对结直肠癌细胞中 microRNA-21 表达的调控。

Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors.

机构信息

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

DNA Cell Biol. 2012 Aug;31(8):1403-11. doi: 10.1089/dna.2011.1469. Epub 2012 May 3.

Abstract

MicroRNAs (miRs) are important regulators of gene expression in normal physiology and disease, and are widely misexpressed in cancer. A number of studies have identified miR-21 as an important promoter of oncogenesis. However, as is true of most miRs, the mechanisms behind the aberrant expression of miR-21 in cancer are poorly understood. Herein, we examine the regulation of miR-21 expression in colorectal cancer (CRC) cells by the oncogenic epidermal growth factor (EGF)/Ras pathway and by Ets transcription factors, modulators of epithelial oncogenesis that are frequently misexpressed in CRC. We show that EGF/Ras efficiently induces the miR-21 primary transcript, but this does not rapidly and simply translate into higher mature miR-21 levels. Rather, induction of mature miR-21 by constitutive activation of this pathway is slow, is associated with only minimal activation of mitogen-activated protein kinase, and may involve stimulation of post-transcriptional processing by mechanisms other than Dicer stabilization. We further identify Ets transcription factors as modifiers of miR-21 expression in CRC. The effects of Ets factors on miR-21 expression are cell context-dependent, and appear to involve both direct and indirect mechanisms. The Ets factor Pea3 emerges from our studies as a consistent repressor of miR-21 transcription. Overall, our studies identify a complex relationship between oncogenic pathways and steady-state miR-21 levels in CRC, and highlight the need for greater understanding of the control of miR expression in cancer and other disease states.

摘要

微小 RNA(miRs)是正常生理和疾病中基因表达的重要调节因子,并且在癌症中广泛表达异常。许多研究已经确定 miR-21 是致癌作用的重要促进剂。然而,与大多数 miRs 一样,miR-21 在癌症中异常表达的机制还了解甚少。在此,我们通过致癌性表皮生长因子(EGF)/Ras 途径和 Ets 转录因子检查了结直肠癌(CRC)细胞中 miR-21 表达的调节,EGF/Ras 途径和 Ets 转录因子是上皮癌发生的调节剂,在 CRC 中经常表达异常。我们表明 EGF/Ras 能有效地诱导 miR-21 的初级转录物,但这不会迅速而简单地转化为更高水平的成熟 miR-21。相反,该途径的组成性激活诱导成熟 miR-21 的速度较慢,与丝裂原活化蛋白激酶的最小激活相关,并且可能涉及通过 Dicer 稳定以外的机制刺激转录后加工。我们进一步确定 Ets 转录因子是 CRC 中 miR-21 表达的调节剂。Ets 因子对 miR-21 表达的影响取决于细胞的上下文,并且似乎涉及直接和间接机制。Ets 因子 Pea3 从我们的研究中脱颖而出,是 miR-21 转录的一致抑制剂。总体而言,我们的研究确定了致癌途径与 CRC 中稳态 miR-21 水平之间的复杂关系,并强调需要更深入地了解癌症和其他疾病状态下 miR 表达的控制。

相似文献

引用本文的文献

本文引用的文献

3
Regression of murine lung tumors by the let-7 microRNA.Let-7 微 RNA 抑制小鼠肺肿瘤生长。
Oncogene. 2010 Mar 18;29(11):1580-7. doi: 10.1038/onc.2009.445. Epub 2009 Dec 7.
4
MicroRNAs as potential cancer therapeutics.微小 RNA 作为潜在的癌症治疗方法。
Oncogene. 2008 Dec;27 Suppl 2(Suppl 2):S52-7. doi: 10.1038/onc.2009.353.
8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验